Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Islet Transplantation in Type 1 Diabetes
NCT00434811Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2006
- Primary completion
- Sep 2012
- Modality
- Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2006; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00434811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434811.